Biology Reference
In-Depth Information
Raab M, Cai YC, Bunnell SC, Heyeck SD, Berg LJ, Rudd CE (1995) p56Lck and p59Fyn regulate
CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2,
and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation. Proc
Natl Acad Sci USA 92:8891-8895
Rouse BT, Sarangi PP, Suvas S (2006) Regulatory T cells in virus infections. Immunol Rev
212:272-286
Rudd CE (1999) Adaptors and molecular scaffolds in immune cell signaling. Cell 96:5-8
Ruppelt A, Mosenden R, Gronholm M, Aandahl EM, Tobin D, Carlson CR, Abrahamsen H,
Herberg FW, Carpen O, Tasken K (2007) Inhibition of T cell activation by cyclic adenosine
5'-monophosphate requires lipid raft targeting of protein kinase A type I by the A-kinase
anchoring protein ezrin. J Immunol 179:5159-5168
Sakaguchi S (2004) Naturally arising CD4
þ
regulatory t cells for immunologic self-tolerance and
negative control of immune responses. Annu Rev Immunol 22:531-562
Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T,
Toda M, Takahashi T (2001) Immunologic tolerance maintained by CD25
þ
CD4
þ
regulatory T
cells: their common role in controlling autoimmunity, tumor immunity, and transplantation
tolerance. Immunol Rev 182:18-32
Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura
T (2006) Foxp3
þ
CD25
þ
CD4
þ
natural regulatory T cells in dominant self-tolerance and
autoimmune disease. Immunol Rev 212:8-27
Skalhegg BS, Landmark BF, Doskeland SO, Hansson V, Lea T, Jahnsen T (1992) Cyclic AMP-
dependent protein kinase type I mediates the inhibitory effects of 3', 5'-cyclic adenosine
monophosphate on cell replication in human T lymphocytes. J Biol Chem 267:15707-15714
Smith FD, Scott JD (2002) Signaling complexes: junctions on the intracellular information super
highway. Curr Biol 12:R32-R40
Smith SJ, Brookes-Fazakerley S, Donnelly LE, Barnes PJ, Barnette MS, Giembycz MA (2003)
Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells.
Am J Physiol Lung Cell Mol Physiol 284:L279-L289
Smith SJ, Cieslinski LB, Newton R, Donnelly LE, Fenwick PS, Nicholson AG, Barnes PJ,
Barnette MS, Giembycz MA (2004) Discovery of BRL 50481 [3-(N, N-dimethylsulfona-
mido)-4-methyl-nitrobenzene], a selective inhibitor of phosphodiesterase 7: in vitro studies
in human monocytes,
lung macrophages, and CD8
þ
T-lymphocytes. Mol Pharmacol
66:1679-1689
Spina D (2003) Theophylline and PDE4 inhibitors in asthma. Curr Opin Pulm Med 9:57-64
Spina D (2008) PDE4 inhibitors: current status. Br J Pharmacol 155:308-315
Tasken K, Aandahl EM (2004) Localized effects of cAMP mediated by distinct routes of protein
kinase A. Physiol Rev 84:137-167
Thompson PE, Manganiello V, Degerman E (2007) Re-discovering PDE3 inhibitors-new oppor-
tunities for a long neglected target. Curr Top Med Chem 7:421-436
Torgersen KM, Vang T, Abrahamsen H, Yaqub S, Horejsi V, Schraven B, Rolstad B,
Mustelin T, Tasken K (2001) Release from tonic inhibition of T cell activation through
transient displacement of C-terminal Src kinase (Csk) from lipid rafts. J Biol Chem 276:
29313-29318
Torgersen KM, Vang T, Abrahamsen H, Yaqub S, Tasken K (2002) Molecular mechanisms for
protein kinase A-mediated modulation of immune function. Cell Signal 14:1-9
Vang T, Torgersen KM, Sundvold V, Saxena M, Levy FO, Skalhegg BS, Hansson V, Mustelin T,
Tasken K (2001) Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent
protein kinase inhibits signaling through the T cell receptor. J Exp Med 193:497-507
Vang T, Abrahamsen H, Myklebust S, Horejsi V, Tasken K (2003) Combined spatial and
enzymatic regulation of Csk by cAMP and protein kinase a inhibits T cell receptor signaling.
J Biol Chem 278:17597-17600
Vlachopoulos C, Terentes-Printzios D, Ioakeimidis N, Rokkas K, Stefanadis C (2009) PDE5
inhibitors in non-urological conditions. Curr Pharm Des 15:3521-3539
